360 related articles for article (PubMed ID: 18300861)
21. Sildenafil reduces cardiovascular remodeling associated with hypertensive cardiomyopathy in NOS inhibitor-treated rats.
Ferreira-Melo SE; Yugar-Toledo JC; Coelho OR; De Luca IM; Tanus-Santos JE; Hyslop S; Irigoyen MC; Moreno H
Eur J Pharmacol; 2006 Aug; 542(1-3):141-7. PubMed ID: 16806160
[TBL] [Abstract][Full Text] [Related]
22. Effects of 5'-phosphodiesterase four-week long inhibition with sildenafil in patients with chronic heart failure: a double-blind, placebo-controlled clinical trial.
Behling A; Rohde LE; Colombo FC; Goldraich LA; Stein R; Clausell N
J Card Fail; 2008 Apr; 14(3):189-97. PubMed ID: 18381181
[TBL] [Abstract][Full Text] [Related]
23. PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers.
Kimura M; Higashi Y; Hara K; Noma K; Sasaki S; Nakagawa K; Goto C; Oshima T; Yoshizumi M; Chayama K
Hypertension; 2003 May; 41(5):1106-10. PubMed ID: 12695418
[TBL] [Abstract][Full Text] [Related]
24. Sildenafil (Viagra) evokes retinal arteriolar dilation: dual pathways via NOS activation and phosphodiesterase inhibition.
Yuan Z; Hein TW; Rosa RH; Kuo L
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):720-5. PubMed ID: 18235020
[TBL] [Abstract][Full Text] [Related]
25. Hemodynamic effects of sildenafil in patients with congestive heart failure and pulmonary hypertension: combined administration with inhaled nitric oxide.
Lepore JJ; Maroo A; Bigatello LM; Dec GW; Zapol WM; Bloch KD; Semigran MJ
Chest; 2005 May; 127(5):1647-53. PubMed ID: 15888841
[TBL] [Abstract][Full Text] [Related]
26. Interaction of sildenafil with cAMP-mediated vasodilation in vivo.
Schalcher C; Schad K; Brunner-La Rocca HP; Schindler R; Oechslin E; Scharf C; Suetsch G; Bertel O; Kiowski W
Hypertension; 2002 Nov; 40(5):763-7. PubMed ID: 12411474
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of sildenafil citrate (Viagra) and tadalafil (Cialis) on sexual responses in Saudi men with erectile dysfunction in routine clinical practice.
Ali ST
Pak J Pharm Sci; 2008 Jul; 21(3):275-81. PubMed ID: 18614424
[TBL] [Abstract][Full Text] [Related]
28. Sildenafil inhibits beta-adrenergic-stimulated cardiac contractility in humans.
Borlaug BA; Melenovsky V; Marhin T; Fitzgerald P; Kass DA
Circulation; 2005 Oct; 112(17):2642-9. PubMed ID: 16246964
[TBL] [Abstract][Full Text] [Related]
29. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure.
Guazzi M; Tumminello G; Di Marco F; Fiorentini C; Guazzi MD
J Am Coll Cardiol; 2004 Dec; 44(12):2339-48. PubMed ID: 15607396
[TBL] [Abstract][Full Text] [Related]
30. Oral sildenafil reduces pulmonary hypertension after cardiac surgery.
Trachte AL; Lobato EB; Urdaneta F; Hess PJ; Klodell CT; Martin TD; Staples ED; Beaver TM
Ann Thorac Surg; 2005 Jan; 79(1):194-7; discussion 194-7. PubMed ID: 15620942
[TBL] [Abstract][Full Text] [Related]
31. Long-term use of sildenafil in the therapeutic management of heart failure.
Guazzi M; Samaja M; Arena R; Vicenzi M; Guazzi MD
J Am Coll Cardiol; 2007 Nov; 50(22):2136-44. PubMed ID: 18036451
[TBL] [Abstract][Full Text] [Related]
32. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
Forfia PR; Lee M; Tunin RS; Mahmud M; Champion HC; Kass DA
J Am Coll Cardiol; 2007 Mar; 49(10):1079-88. PubMed ID: 17349888
[TBL] [Abstract][Full Text] [Related]
33. Effect of sildenafil citrate upon myocardial ischemia in patients with chronic stable angina in therapy with beta-blockers.
Patrizi R; Leonardo F; Pelliccia F; Chierchia SL; Galetta P; Cerquetani E; Frascà F; Fini M; Rosano GM
Ital Heart J; 2001 Nov; 2(11):841-4. PubMed ID: 11770869
[TBL] [Abstract][Full Text] [Related]
34. Effect of sildenafil on middle-aged sexually active males with no erectile complaints: a randomized placebo-controlled double-blind study.
Gruenwald I; Leiba R; Vardi Y
Eur Urol; 2009 Apr; 55(4):969-76. PubMed ID: 18486308
[TBL] [Abstract][Full Text] [Related]
35. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
Webb DJ; Freestone S; Allen MJ; Muirhead GJ
Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
[TBL] [Abstract][Full Text] [Related]
36. Correlation between flow-mediated dilation and erectile dysfunction.
Kovács I; Császár A; Toth J; Siller G; Farkas A; Tarján J; Horváth J; Koller A
J Cardiovasc Pharmacol; 2008 Feb; 51(2):148-53. PubMed ID: 18287882
[TBL] [Abstract][Full Text] [Related]
37. Effects of sildenafil citrate on human hemodynamics.
Jackson G; Benjamin N; Jackson N; Allen MJ
Am J Cardiol; 1999 Mar; 83(5A):13C-20C. PubMed ID: 10078538
[TBL] [Abstract][Full Text] [Related]
38. Sildenafil inhibits duodenal contractility via activation of the NO-K+ channel pathway.
Clemente CM; Araújo PV; Palheta RC; Ratts ZM; Fernandes GH; Rola FH; de Oliveira RB; dos Santos AA; Magalhães PJ
Fundam Clin Pharmacol; 2008 Feb; 22(1):61-7. PubMed ID: 18251723
[TBL] [Abstract][Full Text] [Related]
39. Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients.
Giardini A; Balducci A; Specchia S; Gargiulo G; Bonvicini M; Picchio FM
Eur Heart J; 2008 Jul; 29(13):1681-7. PubMed ID: 18534975
[TBL] [Abstract][Full Text] [Related]
40. Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 diabetic men with erectile dysfunction.
Burnett AL; Strong TD; Trock BJ; Jin L; Bivalacqua TJ; Musicki B
J Urol; 2009 Jan; 181(1):245-51. PubMed ID: 19013603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
